83895 studies found for:    United States
Show Display Options
Rank Status Study
1 Completed Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: CPX-351;   Drug: Cytarabine + Daunorubicin - 7 and 3
2 Completed CAFE Comparison of Atypicals in First Episode of Psychosis
Conditions: Schizophrenia;   Psychotic Disorders;   Mental Health;   Mental Disorders
Intervention: Drug: Olanzapine, risperidone
3 Active, not recruiting A Study To Monitor Long-Term Treatment With PF-00547659
Condition: Crohn's Disease
Intervention: Drug: PF-00547659
4 Completed
Has Results
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Condition: Hyponatremia
Interventions: Drug: Conivaptan;   Drug: Placebo
5 Terminated S9624 Ifosfamide in Treating Patients With Meningeal Tumors
Conditions: Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Rhabdomyosarcoma;   Adult Malignant Meningioma;   Adult Brain Malignant Hemangiopericytoma
Intervention: Drug: ifosfamide
6 Completed Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Hypogonadism
Intervention: Drug: Androgel (testosterone gel)
7 Active, not recruiting
Has Results
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily;   Drug: dolutegravir placebo twice daily;   Drug: Open-label dolutegravir 50mg twice daily
8 Completed
Has Results
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: azelastine HCl/fluticasone propionate;   Drug: azelastine Hcl;   Drug: fluticasone propionate;   Drug: placebo
9 Terminated
Has Results
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: placebo;   Drug: Ziprasidone oral capsules
10 Recruiting S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: R-CHOP regimen;   Other: laboratory biomarker analysis;   Radiation: fludeoxyglucose F 18;   Radiation: selective external radiation therapy;   Radiation: yttrium Y 90 ibritumomab tiuxetan
11 Active, not recruiting FTY720 in Patients With Primary Progressive Multiple Sclerosis
Condition: Primary Progressive Multiple Sclerosis
Interventions: Drug: FTY720;   Drug: Placebo
12 Completed
Has Results
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: vedolizumab;   Other: Placebo
13 Completed Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
Condition: Opioid-Induced Constipation
Interventions: Drug: NKTR-118;   Drug: Placebo
14 Completed Long-term Study of Cariprazine in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Cariprazine
15 Terminated Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Condition: Pulmonary Emphysema
Interventions: Device: Treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
16 Completed A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Levocarnitine;   Drug: Adefovir dipivoxil;   Drug: Saquinavir;   Drug: Delavirdine mesylate
17 Recruiting Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Perioperative/Postoperative Complications;   Radiation Toxicity;   Urinary Complications;   Urinary Tract Toxicity
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
18 Completed A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized Background ARVs
19 Completed Phase 2 Study of TD-9855 to Treat Fibromyalgia
Condition: Fibromyalgia
Interventions: Drug: TD-9855 Group 1;   Drug: TD-9855 Group 2;   Drug: Placebo
20 Completed A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: placebo;   Drug: taspoglutide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years